Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab
Jennifer Collins,1 Gabriele deVos,2 Golda Hudes,2 David Rosenstreich21New York Eye and Ear Infirmary, New York, NY, 2Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, USABackground: Current therapy for allergic bronchopulmonary aspergillosis (ABPA) uses oral corticosteroids,...
Main Authors: | Collins J, de Vos G, Hudes G, Rosenstreich D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-11-01
|
Series: | Journal of Asthma and Allergy |
Online Access: | http://www.dovepress.com/allergic-bronchopulmonary-aspergillosis-treated-successfully-for-one-y-a11467 |
Similar Items
-
Allergic bronchopulmonary aspergillosis treated successfully with omalizumab
by: R. Aguiar, et al.
Published: (2017-09-01) -
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
by: Ashkenazi M, et al.
Published: (2018-06-01) -
Steroid Sparing Effect of Omalizumab in Seropositive Allergic Bronchopulmonary Aspergillosis
by: Keith T. Beam M.D., et al.
Published: (2015-06-01) -
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]
by: Ashkenazi M, et al.
Published: (2018-09-01) -
Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
by: Fernanda Sales da Cunha, et al.